NeuroOne® to Report First Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on February 14
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) will host a conference call on February 14, 2023, at 4:30 PM ET, to discuss its financial results for the fiscal first quarter 2023, ending December 31, 2022. The call will also include a corporate update. Interested parties can join the call via dial-in at 877-405-1216 or through a live webcast here. NeuroOne specializes in minimally invasive solutions for neurological disorders, aiming to enhance surgical care and reduce costs.
- Company committed to improving surgical outcomes for neurological disorders.
- Focuses on minimally invasive technologies, potentially increasing patient accessibility.
- None.
EDEN PRAIRIE, Minn., Feb. 9, 2023 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call to discuss financial results for its fiscal first quarter 2023 ended December 31, 2022 and provide a corporate update on February 14, 2023 at 4:30 PM Eastern Time.
Conference Call and Webcast Information:
Tuesday, February 14, 2023 – 4:30 PM Eastern Time
Participant Dial-In:
877-405-1216 / 201-689-8336
Live Webcast:
Join here
Phone Replay:
877-660-6853 / 201-612-7415, Access ID: 13736384; available through February 28, 2023
Webcast Replay:
Available for 12 months
About NeuroOne
NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit nmtc1.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/neuroone-to-report-first-quarter-fiscal-year-2023-financial-results-and-provide-a-corporate-update-on-february-14-301742866.html
SOURCE NeuroOne Medical Technologies Corporation
FAQ
What date is NeuroOne's Q1 2023 earnings call scheduled for?
How can I access NeuroOne's earnings call?
What will be discussed in NeuroOne's earnings call?
What is NeuroOne's focus in medical technology?
